Trending...
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- Wellesley Dermatologists, Premier Dermatology, Offer Helpful Information about Hair Restoration
- The Business Consultant behind The First Black-owned BP
Social Business model has already donated over 27 million daily servings to children in need.
IRVING, Texas - BostonChron -- Alovéa, a global social business in the health and wellness industry, announced today the launch of a joint project with OneShare Health, a Texas-based medical cost-sharing ministry serving the U.S. The project "CELL•A•BRATE HEALTH" is being launched to dually support the reduction of chronic health events as well as the potential savings in the overall cost of treatment by proactively supporting the body's normal functions of defense and repair.
More on Boston Chron
A select group of OneShare Health members will receive, at no additional cost, a monthly supply of Alovéa's new cellular health/immune optimizing chewables called CELL•A•BRATE. Alovéa founder and CEO Sam Caster says, "Health starts and ends at the cellular level. Through an extensive global search, Alovéa has identified and exclusively licensed and formulated the world's most powerful nutritional extracts for enhancing cellular health into a new tasty chewable that can support the entire family". OneShare Health VP of Sales, Ron Bruno, responded, "We have been exploring opportunities to go beyond providing comprehensive and affordable health sharing services through a proactive investment in the best, science-based health supporting technology and we believe CELL•A•BRATE provides that solution."
More on Boston Chron
To remain consistent with Alovéa's Buy 1, Give 1 platform of social giving, every bottle of CELL•A•BRATE provided to a One Share member in this project, will also generate a full 28 day supply of the same advanced nutritional support to a vulnerable child. "In parts of the world where modern medical care is in short supply, optimizing a child's immune system has often shown to be the difference between life and death. Our Social Business has already donated over 27 million daily servings to children in need and we're just getting started," stated Sam Caster. "This project represents a "first of its kind" philosophical shift in the entire healthcare industry."
The CELL•A•BRATE Health project is scheduled to officially launch in November.
For more information contact:
Linda Padilla
lpadilla@alovea.com
https://alovea.com
More on Boston Chron
- Boston: 2021 day of celebration to honor Rev. Dr. Martin Luther King Jr.
- City houses 1,700 children experiencing housing instability through Boston housing authority vouchers
- Thirteen MBK Senior Living Communities Receive "2021 Best of Senior Living" Distinction
- Grassroots Advocacy Group Urges Biden Administration to Appoint a Doctoral Level Mental Health Professional to Lead SAMHSA
- Boston: January 2021: Latest updates from the Department of Neighborhood Development
A select group of OneShare Health members will receive, at no additional cost, a monthly supply of Alovéa's new cellular health/immune optimizing chewables called CELL•A•BRATE. Alovéa founder and CEO Sam Caster says, "Health starts and ends at the cellular level. Through an extensive global search, Alovéa has identified and exclusively licensed and formulated the world's most powerful nutritional extracts for enhancing cellular health into a new tasty chewable that can support the entire family". OneShare Health VP of Sales, Ron Bruno, responded, "We have been exploring opportunities to go beyond providing comprehensive and affordable health sharing services through a proactive investment in the best, science-based health supporting technology and we believe CELL•A•BRATE provides that solution."
More on Boston Chron
- Zmags Accelerates Growth To Meet Retailers Demand for Innovative Ecommerce Solutions in 2020
- Massachusetts: Governor Baker Signs 'Laura's Law'
- Mayor Walsh celebrates passage of legislation to support creation of affordable housing, workforce training in Boston
- Onto Innovation Schedules 2020 Fourth Quarter and Full Year Financial Results Conference Call for February 4, 2021
- Demolition Delay application: 472A - 472 West Broadway, South Boston
To remain consistent with Alovéa's Buy 1, Give 1 platform of social giving, every bottle of CELL•A•BRATE provided to a One Share member in this project, will also generate a full 28 day supply of the same advanced nutritional support to a vulnerable child. "In parts of the world where modern medical care is in short supply, optimizing a child's immune system has often shown to be the difference between life and death. Our Social Business has already donated over 27 million daily servings to children in need and we're just getting started," stated Sam Caster. "This project represents a "first of its kind" philosophical shift in the entire healthcare industry."
The CELL•A•BRATE Health project is scheduled to officially launch in November.
For more information contact:
Linda Padilla
lpadilla@alovea.com
https://alovea.com
Source: Alovéa
Filed Under: Business
0 Comments
Latest on Boston Chron
- NANOBIOTIX Announces Positive First Results for Novel NBTXR3 in Rectal Cancer Study at ASCO-GI 2021
- Amwell Announces Pricing of Secondary Public Offering
- Atlantic Power Agrees to be Acquired by I Squared Capital
- "Diamond Fuji" to be Seen from TOKYO SKYTREE in February
- BIOMODEX Expands Product Offerings with Innovative Transseptal Puncture Training Solution
- Mayor Walsh announces artists selected for public art projects at Boston Arts Academy and East Boston Police Station
- Boston: Demolition Delay application: 58 Thompson Street, Hyde Park
- Boston: Demolition Delay application: 60 Fuller Street, Dorchester
- The New England Center for Children Commences COVID-19 Vaccine Administration
- Ohana Biosciences Announces Publication in SCIENCE of Foundational Research Demonstrating Unexpected and Widespread Heterogeneity of Human Sperm
- Texpak Offers Environmentally-Friendly Ecotach™ Fasteners to Address Sustainability Needs
- Eaton Vance Corp. Declares Quarterly Dividend
- Morningstar names Quantified STF Fund top-performing tactical-allocation fund in 2020
- Captivate Bio Launches with First Round of High-Quality Cell Culture Tools
- Tamarin Creates First Platform to Connect with COVID Service Providers
- XL Fleet Corp. Files Form S-1 Registration Statement Related to Previously Completed Merger
- SNAP Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Snap Inc (NYSE: SNAP) Investors, Deadline Approaching
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
- Massachusetts: Baker-Polito Administration Re-Files Unemployment Legislation to Provide Employer Relief, Ensure Trust Fund Solvency